VITRAKVI larotrectinib (as sulfate) 100 mg hard capsule bottle

Bayer Australia Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 41d34055e412de2c
Product Name: VITRAKVI larotrectinib (as sulfate) 100 mg hard capsule bottle
Artg Id: 320238
Artg Name: VITRAKVI larotrectinib (as sulfate)100 mg hard capsule bottle
Sponsor: Bayer Australia Ltd
Company Detail Path: /organization/bayer-australia-ltd
Artg Date: 2020-09-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: REP
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-02431-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-02289-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

41d34055e412de2c

Type

Standard